[EN] HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES POUR LA MODULATION DE NR2F6
申请人:TES PHARMA S R L
公开号:WO2021170658A1
公开(公告)日:2021-09-02
The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.
An inexpensive and efficient catalyst system for synthesis of aryl ethers has been developed by using 20 mol% CuI as the catalyst, 30 mol% dimethylaminomethylphosphonic acid derivatives as the new ligands, K2CO3 as the base and toluene as the solvent. This is the first example using aminophosphonates as the ligands for Ullmann ether coupling reaction.
DIARYLETHER INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE
作者:Christopher J Dinsmore*、Theresa M Williams、Kelly Hamilton、Timothy J O'Neill、Elaine Rands、Kenneth S Koblan、Nancy E Kohl、Jackson B Gibbs、Samuel L Graham、George D Hartman、Allen I Oliff
DOI:10.1016/s0960-894x(97)00225-4
日期:1997.5
The design and synthesis of simple nonpeptide inhibitors of farnesyl-protein transferase (FTase) are described. Cysteine-derived diarylether frameworks are appropriate structural replacements for the C-terminal tetrapeptide portion of the Ras protein, and possess in vitro potency against FTase. Inhibitory activity is dependent on the ring-substitution pattern, and does not require the presence of a C-terminal carboxylate group. (C) 1997 Elsevier Science Ltd.
Tomita; Ikawa, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1954, vol. 74, p. 1065,1067